Frontiers in Hematology

Review

Published on 11 May 2026

Bridging innovation and equity: the evolving landscape of CAR T-cell therapy access in Brazil

in Gene Therapy, Cell Therapy and Hematology

Renato Luiz Guerino-Cunha
Andreia Bessa
Angela Marie Jansen
Martha Oliveira
Gayatri Sanku
Rogerio Scarabel
Jayr Schmidt-Filho
Stephen Stefani

Frontiers in Hematology

doi 10.3389/frhem.2026.1813861

408 views

Hypothesis and Theory

Accepted on 06 May 2026

The cells of origin of the chemotherapy curable malignancies are highly sensitive to cytotoxic chemotherapy mediated cell death

in Blood Cancer

Philip Savage
Emily Proudman

Frontiers in Hematology

Original Research

Published on 04 May 2026

Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders

in Blood Cancer

Eilidh M Duncan
Jhulia Salviano
Charalampia Kyriakou
Samantha Nier
Simone Oerlemans
Sam Salek
Kate Morgan
Katie Joyner

Frontiers in Hematology

doi 10.3389/frhem.2026.1800304

557 views

Mini Review

Accepted on 17 Apr 2026

Mechanisms of Kinase Inhibitor Resistance in Subtypes of Cutaneous T-Cell Lymphomas

in Blood Cancer

Julia Yescas
Christopher G Bunick
Ayman Grada
Joan Guitart
Carlos A Torres-Cabala
Isabelle Caroline Le Poole
Alan Zhou

Frontiers in Hematology

363 views

Case Report

Published on 13 Apr 2026

Case Report: Pernicious anemia-associated pancytopenia responds to immunotherapy

in Red Cells, Iron and Erythropoiesis

Alexander Krule
Carlos Murga-Zamalloa
Irum Khan
Ryan Sun
John G. Quigley

Frontiers in Hematology

doi 10.3389/frhem.2026.1733719

404 views

Original Research

Accepted on 08 Apr 2026

A pilot study on therapeutic drug monitoring of Asparaginase in Indian children with high-Risk ALL: Evidence for Suboptimal Exposure

in Blood Cancer

Himanshu Dhanda
Bhavika Rishi
Gratial Theres Joseph
Raj kamal
Manpreet Kaur
Nitika Anand
Fouzia Siraj
Sanghmitra Ray
Amitabh Singh
DR. AROONIMA MISRA

Frontiers in Hematology

397 views

Case Report

Published on 08 Apr 2026

Case Report: A converging pathology: Chediak–Higashi syndrome and IEI-associated lymphoproliferative disease

in Blood Cancer

Carlos R. Varón
Santiago Andrés Suárez-Gómez
Daniela Varón
Libelly Gómez Flórez
Carolina Cortes-Urrea
Elda Graciela Vélez Colmenares
Isabella Corona

Frontiers in Hematology

doi 10.3389/frhem.2025.1650494

1,021 views

Review

Published on 31 Mar 2026

Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms

in Blood Cancer

Gökhan Mergen
Hans C. Hasselbalch

Frontiers in Hematology

doi 10.3389/frhem.2026.1749376

1,172 views

Case Report

Published on 30 Mar 2026

Case Report: Burkitt’s lymphoma with concurrent HIV, CMV encephalitis, and salmonella bacteremia

in Blood Cancer

Elinor Barsh
Michele Basche
Dmitriy Scherbak

Frontiers in Hematology

doi 10.3389/frhem.2026.1727954

414 views

Original Research

Published on 30 Mar 2026

Complications and treatment patterns in patients with non-transfusion-dependent α- and β-thalassemia compared with matched controls: a retrospective observational study using administrative claims data in the United States

in Red Cells, Iron and Erythropoiesis

Arielle L. Langer
Amey Rane
Keely S. Gilroy
Jing Zhao
Louise Lombard
Carolyn R. Lew
Sujit Sheth

Frontiers in Hematology

doi 10.3389/frhem.2026.1770034

557 views

Editorial

Published on 27 Mar 2026

Editorial: Advances and new horizons in cellular therapies for leukemia and myeloma

in Gene Therapy, Cell Therapy and Hematology

Bhavana Bhatnagar
Srinivas Devarakonda

Frontiers in Hematology

doi 10.3389/frhem.2026.1812817

380 views

Perspective

Published on 26 Mar 2026

Castleman disease mimicking systemic lupus erythematosus: the importance of vigilance in diagnosing autoimmune mimickers

in Immunobiology and Immunotherapy

Chao-Chieh Cheng
Ruo-Han Chin
Po-Cheng Shih
Su-Boon Yong
Chia-Jung Li

Frontiers in Hematology

doi 10.3389/frhem.2026.1785387

480 views

Methods

Published on 18 Mar 2026

Single spectral flow cytometry panel for simultaneous detection of hematopoietic stem, progenitor, and mature lineages in mouse bone marrow

in Hematopoiesis and Stem Cells

Léa Girondier
Manon Richaud
Julien MP Grenier
Ana Belen Pérez-Oliva
Jenny Van Asbeck-van der Wijst
Michel Aurrand-Lions
Maria De Grandis
Christophe Lachaud
Cyril Fauriat
Laura Braud

Frontiers in Hematology

doi 10.3389/frhem.2026.1802350

1,021 views

Original Research

Published on 16 Mar 2026

Living with chronic lymphocytic leukaemia: patient perspectives from a global online cross-sectional survey on care pathways and impacts on quality of life

in Blood Cancer

Kathryn Huntley
Alan J. Poots
Sarah Gunn
Jan Rynne
Nick York
Sam Salek

Frontiers in Hematology

doi 10.3389/frhem.2026.1794624

776 views

Case Report

Published on 23 Feb 2026

Case Report: two cases of idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric Castleman disease with xanthelasma palpebrum from a Canadian center

in Blood Cancer

Andrew A. Y. Chen
Vivian T. Yin
Paula Blanco
Mark Trinder
Richard I. Crawford
Ryan Henrie
Stephen Parkin
Nasreen Khalil
Mollie Carruthers
Lu Zhang

Frontiers in Hematology

doi 10.3389/frhem.2026.1745884

755 views
1 citation

Review

Published on 23 Feb 2026

The role of necroptosis as a possible therapeutic target in multiple myeloma: the emerging roles of necroptosis

in Gene Therapy, Cell Therapy and Hematology

Duygu Aydemir

Frontiers in Hematology

doi 10.3389/frhem.2026.1686097

488 views

Case Report

Published on 23 Feb 2026

Rapid response to obinutuzumab and venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases

in Blood Cancer

Emin Abdullayev
Markus Bieringer
Anna Ossami Saidy
Sefer Elezcurtaj
Wolfgang Schneider
Bertram Glaß
Snjezana Janjetovic

Frontiers in Hematology

doi 10.3389/frhem.2026.1776722

451 views

Original Research

Published on 12 Feb 2026

Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia

in Blood Cancer

Gratial Theres Joseph
Sandeep Kumar Swain
Himanshu Dhanda
Neetu Kushwaha
Priti Kumari
Mahek Pravin Khushalani
Rakesh Kumar
Baseer Noor
Sufian Zaheer
Aditi Jain

Frontiers in Hematology

doi 10.3389/frhem.2026.1709697

830 views

Case Report

Published on 04 Feb 2026

Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia

in Blood Cancer

Jiaxin Wu
Hongxiang Wang

Frontiers in Hematology

doi 10.3389/frhem.2026.1748301

830 views

Original Research

Published on 30 Jan 2026

Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation

in Blood Cancer

Vinny Lococo
Maire Okoniewski
Abdalla Shoaib
Leyla Shune
Sunil Abhyankar
Anurag Singh
Dennis Allin
Briha Ansari
Joseph McGuirk
Omar S. Aljitawi

Frontiers in Hematology

doi 10.3389/frhem.2026.1733667

1,538 views

Editorial

Published on 27 Jan 2026

Editorial: Innovations and challenges in sickle cell disease: bridging gaps in global health

in Gene Therapy, Cell Therapy and Hematology

Arturo José Martí-Carvajal

Frontiers in Hematology

doi 10.3389/frhem.2026.1787190

1,002 views

Case Report

Published on 23 Jan 2026

Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma

in Blood Cancer

Guilherme Gasparini Spiandorelo
Ahmed Alnughmush
Olivia Crum
Dragan Jevremovic
J. C. Villasboas

Frontiers in Hematology

doi 10.3389/frhem.2025.1683981

1,288 views

Case Report

Published on 23 Jan 2026

Daratumumab in severe Evans syndrome: a case report

in Immunobiology and Immunotherapy

Stefan M. Hillmann
Hendrik Brockhoff
Sarah Loebel
Suna Hentschke
Dirk Arnold
Hans Salwender

Frontiers in Hematology

doi 10.3389/frhem.2025.1719208

1,334 views

Original Research

Published on 21 Jan 2026

Too soon to switch? Early TKI switching vs. continuous monotherapy: long-term outcomes in chronic myeloid leukemia

in Blood Cancer

Muluken Megiso
Chidiebube Ugwu
Elvis Obomanu
Alankrita Taneja

Frontiers in Hematology

doi 10.3389/frhem.2025.1730554

1,126 views

190 articles

articles

Bridging innovation and equity: the evolving landscape of CAR T-cell therapy access in Brazil

The cells of origin of the chemotherapy curable malignancies are highly sensitive to cytotoxic chemotherapy mediated cell death

Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders

Mechanisms of Kinase Inhibitor Resistance in Subtypes of Cutaneous T-Cell Lymphomas

Case Report: Pernicious anemia-associated pancytopenia responds to immunotherapy

A pilot study on therapeutic drug monitoring of Asparaginase in Indian children with high-Risk ALL: Evidence for Suboptimal Exposure

Case Report: A converging pathology: Chediak–Higashi syndrome and IEI-associated lymphoproliferative disease

Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms

Case Report: Burkitt’s lymphoma with concurrent HIV, CMV encephalitis, and salmonella bacteremia

Complications and treatment patterns in patients with non-transfusion-dependent α- and β-thalassemia compared with matched controls: a retrospective observational study using administrative claims data in the United States

Editorial: Advances and new horizons in cellular therapies for leukemia and myeloma

Castleman disease mimicking systemic lupus erythematosus: the importance of vigilance in diagnosing autoimmune mimickers

Single spectral flow cytometry panel for simultaneous detection of hematopoietic stem, progenitor, and mature lineages in mouse bone marrow

Living with chronic lymphocytic leukaemia: patient perspectives from a global online cross-sectional survey on care pathways and impacts on quality of life

Case Report: two cases of idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric Castleman disease with xanthelasma palpebrum from a Canadian center

The role of necroptosis as a possible therapeutic target in multiple myeloma: the emerging roles of necroptosis

Rapid response to obinutuzumab and venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases

Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia

Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia

Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation

Editorial: Innovations and challenges in sickle cell disease: bridging gaps in global health

Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma

Daratumumab in severe Evans syndrome: a case report

Too soon to switch? Early TKI switching vs. continuous monotherapy: long-term outcomes in chronic myeloid leukemia